Tech Company Financing Transactions
Nfocus Neuromedical Funding Round
Nfocus Neuromedical, operating out of Palo Alto, secured $6 million from Edison Partners and Lazard Technology Partners.
Transaction Overview
Company Name
Announced On
9/1/2004
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Edison Partners (Lead Investor) (Michael Helmicki)
Proceeds Purpose
This new funding will enable NFR to continue its aggressive development of cutting edge security products to meet these customers' and market needs.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
2191 East Bayshore Road 100
Palo Alto, CA 94303
USA
Palo Alto, CA 94303
USA
Phone
Website
Email Address
Overview
Nfocus Neuromedical is a neurovascular development, manufacturing and marketing company focused on treating hemorrhagic stroke. Product development programs are aimed at Neurovascular Embolization Covers - a new technology providing rapid treatment of aneurysms and fistulas in the brain. The company was created after CardioVasc acquired Acta Vascular in 2007, and the new combined entity was renamed to be Nfocus Neuromedical.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Milledge
Browse more venture capital transactions:
Prev: 9/1/2004: Bolt Solutions venture capital transaction
Next: 9/3/2004: Vascular Architects venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs